UPDATE 1-GSK to partner with Vir for potential COVID-19 treatments, invest $250 mln
April 06, 2020 at 09:23 AM EDT
British drugmaker GlaxoSmithKline will invest $250 million in Vir Biotechnology Inc and collaborate to develop potential treatments for COVID-19, the disease caused by the new coronavirus, the companies said on Monday.
